The level of cyclin-dependent kinase inhibitor p27 Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells

RAŠKOVÁ KAFKOVÁ, L., Veronika NAVRKALOVÁ, Marie JAROŠOVÁ, Tomáš LOJA, Jana ČERNÁ, Jana FIALOVÁ KUČEROVÁ, E. KRIEGOVÁ, V. PROCHÁZKA, Zdeněk NOVÁK, Dagmar ŠIMKOVÁ, Šárka POSPÍŠILOVÁ and Vladimír DIVOKÝ. The level of cyclin-dependent kinase inhibitor p27 Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells. In International Conference Analytical Cytometry IX, Praha. 2017.

Basic information

Original name

The level of cyclin-dependent kinase inhibitor p27 Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells

Authors

RAŠKOVÁ KAFKOVÁ, L., Veronika NAVRKALOVÁ, Marie JAROŠOVÁ, Tomáš LOJA, Jana ČERNÁ, Jana FIALOVÁ KUČEROVÁ, E. KRIEGOVÁ, V. PROCHÁZKA, Zdeněk NOVÁK, Dagmar ŠIMKOVÁ, Šárka POSPÍŠILOVÁ and Vladimír DIVOKÝ

Edition

International Conference Analytical Cytometry IX, Praha, 2017

---

Other information

Type of outcome

Konferenční abstrakt

Field of Study

30200 3.2 Clinical medicine

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology